Log in
Enquire now
‌

US Patent 9532992 Substituted benzene compounds

Patent 9532992 was granted and assigned to Epizyme on January, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Epizyme
Epizyme
Current Assignee
Epizyme
Epizyme
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9532992
Date of Patent
January 3, 2017
Patent Application Number
14742466
Date Filed
June 17, 2015
Patent Citations Received
‌
US Patent 11839663 Radiolabelled MGL pet ligands
0
‌
US Patent 11820766 Monoacylglycerol lipase modulators
0
‌
US Patent 11820770 P2X7 modulators
0
Patent Primary Examiner
‌
Shirley V Gembeh
Patent abstract

The present invention relates to substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9532992 Substituted benzene compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.